NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NBIX is currently covered by 24 analysts with an average price target of $163.22. This is a potential upside of $27.79 (20.52%) from yesterday's end of day stock price of $135.43.

Neurocrine Biosciences's activity chart (see below) currently has 341 price targets and 318 ratings on display. The stock rating distribution of NBIX is 76.7% BUY and 23.3% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.62% with an average time for these price targets to be met of 268.32 days.

Highest price target for NBIX is $184, Lowest price target is $115, average price target is $163.88.

Most recent stock forecast was given by PAUL MATTEIS from STIFEL on 31-Jul-2025. First documented stock forecast 04-Feb-2015.

Currently out of the existing stock ratings of NBIX, 79 are a BUY (76.7%), 24 are a HOLD (23.3%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$174

$38.57 (28.48%)

$144

24 days ago
(31-Jul-2025)

19/20 (95%)

$45.77 (35.69%)

504

Buy

$158

$22.57 (16.67%)

$150

24 days ago
(31-Jul-2025)

7/13 (53.85%)

$29.77 (23.22%)

453

Buy

$141

$5.57 (4.11%)

$147

24 days ago
(31-Jul-2025)

11/13 (84.62%)

$12.77 (9.96%)

476

Buy

$144

$8.57 (6.33%)

$145

24 days ago
(31-Jul-2025)

17/22 (77.27%)

$15.77 (12.30%)

117

Buy

$175

$39.57 (29.22%)

$154

24 days ago
(31-Jul-2025)

13/17 (76.47%)

$46.77 (36.47%)

375

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 268.32 days on average for the stock forecasts to be realized with a an average price target met ratio 76.62

Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Danielle Brill works at RAYMOND JAMES and has 7 price targets and 7 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Jay Olson with highest potential upside - $83.57

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Thomas Wei with lowest potential downside - -$69.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?